These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31041642)

  • 1. Loss of Tyrosine Phosphatase Delta Promotes Gastric Cancer Progression via Signal Transducer and Activator of Transcription 3 Pathways.
    Wu L; Gao L; Kong D; Xue H
    Dig Dis Sci; 2019 Nov; 64(11):3164-3172. PubMed ID: 31041642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma.
    Wang D; Wang L; Zhou J; Pan J; Qian W; Fu J; Zhang G; Zhu Y; Liu C; Wang C; Jin Z; He Z; Wu J; Shi B
    PLoS One; 2014; 9(11):e113754. PubMed ID: 25412184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin.
    Bae WJ; Ahn JM; Byeon HE; Kim S; Lee D
    J Exp Clin Cancer Res; 2019 Dec; 38(1):484. PubMed ID: 31805999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human epidermal growth factor receptor 2 expressions and Janus-activated kinase/signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway may be associated with clinicopathological features and prognosis of gastric cancer.
    Xu W; Fu J; Wu H; Sun W
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S311-S318. PubMed ID: 29970682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
    Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
    Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
    Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.
    Wu C; Zhu X; Liu W; Ruan T; Wan W; Tao K
    Oncol Rep; 2018 Sep; 40(3):1565-1573. PubMed ID: 30015981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis.
    Ortiz B; Fabius AW; Wu WH; Pedraza A; Brennan CW; Schultz N; Pitter KL; Bromberg JF; Huse JT; Holland EC; Chan TA
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8149-54. PubMed ID: 24843164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium-dependent Phosphatase (MDP) 1 is a Potential Suppressor of Gastric Cancer.
    Zhu J; Deng L; Chen B; Huang W; Lin X; Chen G; Tzeng CM; Ying M; Lu Z
    Curr Cancer Drug Targets; 2019; 19(10):817-827. PubMed ID: 31218958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
    Veeriah S; Brennan C; Meng S; Singh B; Fagin JA; Solit DB; Paty PB; Rohle D; Vivanco I; Chmielecki J; Pao W; Ladanyi M; Gerald WL; Liau L; Cloughesy TC; Mischel PS; Sander C; Taylor B; Schultz N; Major J; Heguy A; Fang F; Mellinghoff IK; Chan TA
    Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9435-40. PubMed ID: 19478061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
    Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
    Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation.
    Zhang F; Wang B; Qin T; Wang L; Zhang Q; Lu Y; Song B; Yu X; Li L
    Mol Cell Biochem; 2020 Oct; 473(1-2):1-13. PubMed ID: 32602014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of human kallikrein 12 gene expression in gastric cancer.
    Zhao EH; Shen ZY; Liu H; Jin X; Cao H
    World J Gastroenterol; 2012 Dec; 18(45):6597-604. PubMed ID: 23236234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
    Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
    Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD24 mediates gastric carcinogenesis and promotes gastric cancer progression via STAT3 activation.
    Wang YC; Wang JL; Kong X; Sun TT; Chen HY; Hong J; Fang JY
    Apoptosis; 2014 Apr; 19(4):643-56. PubMed ID: 24327257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of Piwil3 suppresses cell proliferation, migration and invasion in gastric cancer.
    Jiang L; Wang WJ; Li ZW; Wang XZ
    Cancer Biomark; 2017 Dec; 20(4):499-509. PubMed ID: 28869440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells.
    Lv XY; Wang J; Huang F; Wang P; Zhou JG; Wei B; Li SH
    Oncol Rep; 2018 Oct; 40(4):2408-2416. PubMed ID: 30066881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis.
    Xu L; Zhou R; Yuan L; Wang S; Li X; Ma H; Zhou M; Pan C; Zhang J; Huang N; Shi M; Bin J; Liao Y; Liao W
    Cancer Lett; 2017 May; 393():76-85. PubMed ID: 28223169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.